Skip to search formSkip to main contentSkip to account menu

Zuclopenthixol dihydrochloride

Known as: (Z)-4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol Dihydrochloride, Zuclopenthixol Hydrochloride, cis-Clopenthixol Hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Objective: Prescribers are warned to be vigilant for potential cytochrome P450 mediated drug interactions; guidelines separately… 
Review
2009
Review
2009
We searched the Cochrane Schizophrenia Group’s register (December 2004). This register is compiled of methodical searches of… 
2009
2009
The computer‐assisted development of a CE method for compliance monitoring of a group of 17 antipsychotic drugs (chlorpromazine… 
Review
2005
Review
2005
BACKGROUND Zuclopenthixol dihydrochloride, given orally, is commonly used for managing the signs and symptoms of schizophrenia… 
1990
1990
Restlessness, aggressiveness and agitation in elderly people with dementia sometimes requires treatment with drugs. Often… 
1987
1987
An assessment of the efficacy and tolerability of zuclopenthixol dihydrochloride tablets in the treatment of acute psychotic… 
1987
1987
The single-dose kinetics of the neuroleptic thioxanthene zuclopenthixol was assessed in 12 healthy volunteers who ingested 10 mg… 
1987
1987
An open study was undertaken to assess the efficacy and tolerance of oral zuclopenthixol in 40 patients with functional psychotic… 
1985
1985
An open, multi-centre study was carried out in 69 patients with an acute psychotic episode to assess the efficacy and side…